Search research articles
Contact Us
Filters
Showing results (321-330 of 328) with videos related to
Page
of 33
Sort By:
You have reached the last page of results.
This site can display upto 328 results.
Journal for Immunotherapy of Cancer
|
October 17, 2022
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Xiaolu Yu, Yiru Long, Binfan Chen, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood
Shuzhen Chen, Yaping Dong, Xinming Qi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 22, 2012
Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells
Peng Chen, Xiu-Li Wang, Zhong-Sen Ma, et al.
Biochemical and Biophysical Research Communications
|
May 22, 2026
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines
Shuai Shao, Ze Yuan Dong, Zi Yao Kang, et al.
Journal of Integrative Plant Biology
|
January 9, 2026
Plastid and nuclear phylogenomics of Cyphostemma (Vitaceae) provide new insights into genome size evolution across sub-Saharan Africa
Rindra M Ranaivoson, Romer N Rabarijaona, Jin-Ren Yu, et al.
Cancer Cell
|
September 14, 2016
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo, Tong Zheng, Baoen Chen, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
January 8, 2013
[Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities]
You-ning Liu, Bin Cao, Hui Wang, et al.
Cell Discovery
|
February 1, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity
Yiru Long, Jianhua Sun, Tian-Zhang Song, et al.
Page
of 33
Search research articles
Search
Showing results (321-330 of 328) with videos related to
Sort By:
Page
of 33
You have reached the last page of results.
This site can display upto 328 results.
Journal for Immunotherapy of Cancer
|
October 17, 2022
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Xiaolu Yu, Yiru Long, Binfan Chen, et al.
Acta Pharmaceutica Sinica. B
|
June 1, 2022
Aristolochic acids exposure was not the main cause of liver tumorigenesis in adulthood
Shuzhen Chen, Yaping Dong, Xinming Qi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
September 22, 2012
Knockdown of HMGN5 expression by RNA interference induces cell cycle arrest in human lung cancer cells
Peng Chen, Xiu-Li Wang, Zhong-Sen Ma, et al.
Biochemical and Biophysical Research Communications
|
May 22, 2026
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines
Shuai Shao, Ze Yuan Dong, Zi Yao Kang, et al.
Journal of Integrative Plant Biology
|
January 9, 2026
Plastid and nuclear phylogenomics of Cyphostemma (Vitaceae) provide new insights into genome size evolution across sub-Saharan Africa
Rindra M Ranaivoson, Romer N Rabarijaona, Jin-Ren Yu, et al.
Cancer Cell
|
September 14, 2016
Small-Molecule Targeting of E3 Ligase Adaptor SPOP in Kidney Cancer
Zhong-Qiang Guo, Tong Zheng, Baoen Chen, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases
|
January 8, 2013
[Adult hospital acquired pneumonia: a multicenter study on microbiology and clinical characteristics of patients from 9 Chinese cities]
You-ning Liu, Bin Cao, Hui Wang, et al.
Cell Discovery
|
February 1, 2022
CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity
Yiru Long, Jianhua Sun, Tian-Zhang Song, et al.
Page
of 33